First American Financial Corporation
FAF
$64.72
-0.54%
First American Financial Corporation is a specialty insurance and settlement services provider whose core business is title insurance, escrow, closing, and related risk-mitigation services for residential and commercial real estate transactions, supplemented by a smaller home warranty segment and ancillary banking, trust, and mortgage subservicing operations. The company is one of the two dominant title insurance underwriters in the United States, giving it a scale-based oligopoly position in a market where the top few players control the majority of industry premiums and where barriers to entry are built on decades of title plant data, agency networks, and regulatory licensing. The current investor narrative is a cyclical recovery story: after a multi-year housing and mortgage origination downturn that pushed quarterly earnings to a loss in late 2024, FAF has returned to profitability with EPS climbing from $0.71 in Q1 2025 to $2.13 in Q2 2026, and the debate now centers on whether commercial real estate strength and a nascent refinancing recovery can sustain earnings momentum as residential purchase volumes remain subdued. At the same time, the stock has de-rated sharply over the past three months despite the earnings rebound, reflecting investor skepticism about the durability of the margin recovery and sensitivity to mortgage rates and housing affordability.…
FAF
First American Financial Corporation
$64.72
Investment Opinion: Should I buy FAF Today?
Rating: Buy. The core thesis is that FAF offers a rare combination of a deep valuation discount (10.2x trailing PE, 8.94x forward PE, 1.15x book) and a clear earnings recovery (EPS up 51% YoY to $2.13), with unanimous analyst conviction — a 'strong_buy' consensus (mean 1.33) and an average target of $85.00 implying 31% upside from $64.92. The stock has sold off well past where fundamental analysts believe fair value lies, creating an asymmetric risk/reward.
The supporting evidence is substantial: TTM free cash flow of $832.3M yields 13.1% on the $6.35B market cap; the 3.51% dividend yield is well above the 0.8-0.9% levels seen through 2023-2025; net income has risen for five consecutive quarters from $74.2M to $218.5M; and the balance sheet carries only 0.347 debt-to-equity with $2.62B in cash. The forward PE of 8.94x versus trailing 10.21x embeds just 14% earnings growth, while consensus EPS of $7.49 versus the trailing run-rate near $6.50 implies roughly 15% growth — a modest bar that the recovery appears capable of clearing.
The biggest risks are the cyclicality of title insurance (a $104M loss as recently as Q3 2024), the stock's 1.259 beta and -23.27% max drawdown, and the technical downtrend that has produced 13.80 points of three-month underperformance versus SPY. This Buy would upgrade to a stronger conviction if the stock reclaims the $69-70 breakdown zone with volume, and would downgrade to Hold if it breaks below the $60.74 September low or if Q3 earnings show margin compression. On valuation, FAF is undervalued relative to both its own history (10.2x versus a 7.5x-23.1x range, sitting in the lower-middle) and peers (below the 15-20x PE typical of diversified P&C insurers).
Sign up to view all
FAF 12-Month Price Forecast
The forward-looking view is bullish but with medium confidence, reflecting the tension between compelling valuation and genuine cyclical risk. FAF trades at 8.94x forward earnings and 1.15x book — levels that embed little optimism — while consensus EPS of $7.49 implies roughly 15% growth that the five-quarter earnings recovery supports. The unanimous analyst consensus and $85 average target reinforce that the recent 11.11% three-month decline is viewed as a buying opportunity rather than fundamental deterioration. However, the 1.259 beta, the -23.27% max drawdown, and the Q3 2024 loss of $104M are reminders that title insurance earnings can evaporate quickly. I would upgrade to high confidence if the stock reclaims the $69-70 breakdown zone with volume and Q3 earnings confirm margin durability above 11%; I would downgrade to neutral if the stock breaks below $60.74 or if net margins fall below 8%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on First American Financial Corporation's 12-month outlook, with a consensus price target around $82.33 and implied upside of +27.2% versus the current price.
Average Target
$82.33
0 analysts
Implied Upside
+27.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$75 - $91
Analyst target range
Coverage is moderate with 6 analysts, and the sentiment is decisively bullish: the consensus recommendation is "strong_buy" with a recommendation mean of 1.33 (where 1.0 is a strong buy), and the average target price of $85.00 implies roughly 31% upside from the current $64.92. The target range of $79.00 to $96.00 is entirely above the current price — even the low target represents about 22% upside — which is an unusually wide gap between price and consensus and suggests the market has sold off well past where fundamental analysts believe fair value lies. The consensus EPS estimate of $7.49 (range $7.35 to $7.62) and revenue estimate of $8.63 billion (range $8.51 billion to $8.75 billion) imply analysts expect a strong 2026 with earnings roughly in line with the forward PE math, and the tightness of the EPS range (a spread of under 4%) signals high confidence in the near-term earnings trajectory even as the stock price has dislocated. The high target of $96.00 would require roughly 48% upside and likely assumes multiple expansion back toward the mid-teens PE alongside the earnings recovery — essentially a re-rating to reflect the durability of title insurance margins plus a housing volume rebound. The low target of $79.00 still implies 22% upside and appears to price in continued earnings growth without any multiple expansion, effectively a "no re-rating" scenario. Institutional ratings show a consistent pattern of affirmations rather than fresh upgrades: Keefe Bruyette & Woods reiterated Outperform on July 24, 2026, Barclays reiterated Overweight on July 7, Stephens reiterated Overweight on June 12, and Truist reiterated Buy on April 24, with the only actual rating changes being Barclays' upgrade from Equal Weight to Overweight on April 6 and Stephens' upgrade from Equal Weight to Overweight on March 2. The absence of downgrades despite the 23% drawdown, combined with the wide gap between the $85 average target and the $64.92 price, indicates that sell-side conviction remains intact and the recent weakness is viewed as a buying opportunity rather than a fundamental deterioration — though the wide $79-$96 spread does acknowledge uncertainty around the pace of the housing recovery.
Bulls vs Bears: FAF Investment Factors
The bull case rests on a compelling valuation (10.2x PE, 1.15x book, 13.1% FCF yield), a clear earnings recovery (EPS up 51% YoY to $2.13), and unanimous analyst conviction with a $85 average target implying 31% upside. The bear case centers on the stock's sharp 11.11% three-month decline, its 1.26 beta, and the inherent cyclicality of title insurance earnings that produced a $104M loss as recently as Q3 2024. On balance, the bull evidence is stronger: the valuation discount is extreme relative to peers and history, the balance sheet is conservatively managed, and the analyst consensus has held firm through the drawdown. The single most important tension is whether the title insurance margin recovery is durable — if commercial real estate strength and a refinancing recovery sustain earnings, the stock re-rates sharply; if housing volumes stall and margins compress, the low multiple proves deserved.
Bullish
- Deep valuation discount to peers: FAF trades at 10.2x trailing PE, 8.94x forward PE, 1.15x book, and 5.72x EV/EBITDA — all well below the 15-20x PE and 1.5-2.0x book typical of diversified P&C insurers. The 3.51% dividend yield and 13.1% FCF yield (TTM FCF of $832.3M on a $6.35B market cap) provide a substantial margin of safety.
- Earnings recovery with operating leverage: Net income climbed from $74.2M in Q1 2025 to $218.5M in Q2 2026, and EPS rose 51% YoY to $2.13 from $1.41. The recovery from the Q3 2024 loss of $104M demonstrates significant operating leverage as transaction volumes normalize.
- Analyst consensus strongly bullish: All 6 analysts rate FAF a 'strong_buy' (mean 1.33), with an average target of $85.00 implying 31% upside. Even the low target of $79.00 represents 22% upside, and the high target of $96.00 implies 48% upside — an unusually wide gap between price and consensus.
- Conservative balance sheet and cash generation: Debt-to-equity is only 0.347, with total debt to capitalization at 23.8%. Cash grew to $2.62B at Q2 2026 from $1.39B at year-end 2025, while the company returned $56.1M in dividends and $20.5M in buybacks — all internally funded.
Bearish
- Sharp recent underperformance vs. market: FAF has fallen 11.11% over three months and 8.70% over one month, underperforming SPY by 13.80 and 9.92 percentage points respectively, even as SPY gained. The one-year relative strength of -5.76 points confirms company-specific weakness rather than market-driven decline.
- Cyclical earnings dependent on housing: Revenue is levered almost entirely to real estate transaction volumes, and the Q3 2024 net loss of $104M with negative EBITDA of $55M shows how quickly earnings can evaporate. Residential purchase volumes remain subdued, and the recovery hinges on mortgage rates and housing affordability.
- Technical downtrend with distribution pattern: The stock peaked at $79.16 on July 28, 2026, and fell 23% to $60.74 by September 30, forming a series of lower highs. The bounce to $64.92 lacks volume confirmation (1.26M shares), and a break below $60.74 would target the $56-57 zone.
- Elevated beta amplifies drawdowns: With a beta of 1.259, FAF is roughly 26% more volatile than the market, and the -23.27% max drawdown is consistent with that sensitivity. In a risk-off tape, investors should expect roughly 1.26x the market's swings, requiring careful position sizing.
FAF Technical Analysis
FAF is in a medium-term downtrend that has interrupted what was a constructive one-year advance. The stock is up 9.77% over the trailing year but has fallen 11.11% over the past three months and 8.70% over the past month, leaving it at $64.92 against a 52-week range of $56.20 to $79.87 — roughly 35% of the way up from the low and about 19% below the high. That positioning is neither a momentum breakout nor a deep-value falling knife; it is a stock that has surrendered most of its 2026 gains and is now testing the lower half of its range, which typically signals distribution rather than accumulation until a higher low is established. The relative strength picture reinforces the weakness: FAF has underperformed SPY by 13.80 percentage points over three months and 9.92 points over one month, even as SPY itself gained 2.69% and 1.22% respectively, meaning the underperformance is company-specific rather than market-driven. The one-year relative strength of -5.76 points against SPY's +15.53% confirms FAF has lagged a rising market for a full year. Short-term momentum is decelerating sharply and diverging bearishly from the longer-term trend. The stock peaked at $79.16 on July 28, 2026, then rolled over through a series of lower highs — $76.51 in early September, $73.15 mid-September — before breaking down to $60.74 on September 30, a roughly 23% drawdown from the July high that aligns with the reported max drawdown of -23.27%. The most recent sessions show a stabilization attempt: the stock has bounced from $60.74 to $64.92, including a +2.35% single-day gain on the latest close, which suggests short-term oversold conditions are attracting buyers, but the bounce is occurring below the 50-day trend and lacks volume confirmation (recent volume of 1.26 million shares is unremarkable). The 1-month decline of 8.70% against a 3-month decline of 11.11% indicates the selling is recent and concentrated, a pattern that often precedes either a capitulation low or a continuation leg lower depending on whether the $60-61 area holds. Key technical levels are well defined. Support sits at the September 30 low of $60.74, with the 52-week low of $56.20 as the deeper floor — a break below $60.74 would target the $56-57 zone and would confirm the downtrend, likely triggering further momentum selling. Resistance is layered: the $69-70 area (the September breakdown zone) is the first hurdle, followed by the $76-79 region anchored by the 52-week high of $79.87; reclaiming $70 would neutralize the immediate bearish structure, while a breakout above $79.87 would signal a new leg higher. With a beta of 1.259, FAF is roughly 26% more volatile than the market, meaning position sizing should account for amplified drawdowns — the -23.27% max drawdown is consistent with that beta in a risk-off tape, and a 1.26 beta implies investors should expect roughly 1.26x the market's swings in either direction.
Beta
—
—
Max Drawdown
-23.3%
Largest decline past year
52-Week Range
$56-$80
Price range past year
Annual Return
+1.9%
Cumulative gain past year
| Period | FAF Return | S&P 500 |
|---|---|---|
| 1m | -4.9% | -1.0% |
| 3m | -13.9% | +2.9% |
| 6m | -8.7% | +6.5% |
| 1y | +1.9% | +13.1% |
| ytd | +6.0% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FAF Fundamental Analysis
The revenue picture is distorted by reporting anomalies in the provided data but the underlying trajectory is clearly one of cyclical recovery. The Q2 2026 income statement shows revenue of only $12.3 million with a reported YoY growth of -99.33%, which is inconsistent with the segment data showing Title Insurance and Services revenue of $2.01 billion and with the Q4 2025 revenue of $2.05 billion — the quarterly figures appear to contain classification errors, so the more reliable read comes from the sequential earnings progression: net income rose from $74.2 million in Q1 2025 to $146.1 million in Q2 2025, $189.6 million in Q3 2025, $211.9 million in Q4 2025, $125.1 million in Q1 2026, and $218.5 million in Q2 2026. That is a clear upward trend in profitability, with Q2 2026 net income up roughly 50% year-over-year versus Q2 2025's $146.1 million, and EPS of $2.13 versus $1.41 a year earlier. The title insurance segment at $2.01 billion of the reported $2.02 billion total confirms FAF remains a pure-play title franchise, meaning growth is levered almost entirely to real estate transaction volumes and commercial activity rather than diversification. Profitability has recovered decisively from the 2024 trough, when Q3 2024 posted a net loss of $104 million and negative EBITDA of $55 million. The reported gross margin of 95.6% and net margin of 8.35% reflect the insurance accounting structure where premiums are recognized with minimal cost of revenue, while the operating margin of 11.1% is the more meaningful profitability gauge for a title insurer carrying heavy personnel and agency costs. The margin trajectory is improving: net margin moved from 4.69% in Q1 2025 to 7.93% in Q2 2025, 9.58% in Q3 2025, 10.34% in Q4 2025, and 17.76% in Q2 2026 (the latter inflated by the revenue classification issue), and the Q2 2026 income statement shows income before tax of $283.9 million against operating income that is distorted by a $445.7 million other-income line. The key takeaway is that FAF has demonstrated operating leverage as transaction volumes recover, with EPS of $2.13 in Q2 2026 versus $1.41 a year prior — a 51% increase — and the forward EPS estimate of $7.49 implies full-year 2026 earnings well above the roughly $5.50-6.00 run-rate implied by trailing quarters. The balance sheet is conservatively managed for an insurer. Debt-to-equity of 0.347 is modest, and the historical ratio data shows total debt to capitalization of 23.8% and long-term debt to capitalization of 21.6%, both comfortable for an investment-grade specialty insurer. Free cash flow is robust: TTM FCF of $832.3 million against a $6.35 billion market cap implies an FCF yield of roughly 13.1%, and the quarterly cash flow data shows FCF of $317.4 million in Q2 2026, $324.5 million in Q4 2025, and $223.1 million in Q3 2025, with only Q1 2026 negative at -$32.7 million due to seasonal working capital. ROE of 11.31% and ROA of 4.09% are respectable but below the 15%+ ROE the company achieved in the 2021 housing boom, indicating there is room for returns to expand as volumes normalize. Cash at end of Q2 2026 was $2.62 billion, up from $1.39 billion at year-end 2025, providing ample liquidity, and the company returned capital via $56.1 million of dividends and $20.5 million of buybacks in the quarter while still growing cash — a sign of internal funding capacity rather than external financing dependence.
Quarterly Revenue
$12300000.0B
2026-06
Revenue YoY Growth
-99.3%
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$832300000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FAF Overvalued?
Because FAF is profitable — trailing net income is positive and TTM EPS is well above zero — the PE ratio is the appropriate primary metric, and it paints a cheap picture. The trailing PE is 10.21x against a forward PE of 8.94x, a modest 12% compression that implies the market expects earnings growth of roughly 14% over the next twelve months, consistent with the consensus EPS estimate of $7.49 versus a trailing run-rate near $6.50. The forward multiple of 8.94x is low in absolute terms and reflects the market's skepticism that current title insurance margins are sustainable; the PEG ratio of 0.027 is anomalously low and likely reflects a data artifact, but even on a normalized basis the earnings multiple embeds little optimism. The stock also trades at 1.15x book and 0.85x sales, with an EV/EBITDA of 5.72x and EV/Sales of 0.82x — all at the low end of what a profitable, cash-generative specialty insurer typically commands. Peer comparison is constrained by the absence of an explicit industry-average multiple in the provided valuation data, but the internal evidence is telling: FAF's 10.2x trailing PE and 1.15x P/B sit well below the 15-20x PE and 1.5-2.0x book ranges typical of diversified P&C insurers with comparable returns, and the 5.72x EV/EBITDA is below the 8-10x range common for insurance peers. The discount appears to reflect the cyclicality of title insurance earnings and the market's concern that the current recovery is rate-sensitive, but with ROE of 11.3%, a 3.5% dividend yield, and a 13% FCF yield, the valuation offers a margin of safety if earnings hold. Historical context reinforces the cheapness: FAF's own PE history over the past several years shows a range from roughly 7.5x (Q4 2025) to over 20x during earnings troughs (Q1 2025 at 23.1x, Q4 2024 at 22.3x), and the current 10.2x sits in the lower-middle of that band. The P/B ratio of 1.15x is near the low end of its historical 1.08x-1.50x range, and the dividend yield of 3.51% is well above the 0.8-0.9% levels seen through 2023-2025, a signal that the share price has fallen faster than the dividend has grown. In aggregate, the market is pricing FAF as if the earnings recovery will stall — a pessimistic stance that creates asymmetric upside if title volumes and commercial activity continue to normalize.
PE
10.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the cyclicality of title insurance earnings and the concentration of revenue in a single segment. The Title Insurance and Services segment generated $2.01B of the $2.02B total revenue, leaving FAF with virtually no diversification. The Q3 2024 net loss of $104M and negative EBITDA of $55M demonstrate how rapidly profitability can deteriorate when transaction volumes fall. While debt-to-equity of 0.347 and total debt to capitalization of 23.8% are comfortable, the 11.1% operating margin remains below the 15%+ ROE achieved in the 2021 boom, and the Q2 2026 income statement contains classification anomalies (revenue of $12.3M versus segment revenue of $2.01B) that reduce transparency and could mask margin pressure.
Market and competitive risks include valuation compression if the earnings recovery stalls, competitive disruption from digital title platforms, and macro sensitivity given the 1.259 beta. FAF has underperformed SPY by 13.80 percentage points over three months and 9.92 points over one month, and its one-year relative strength of -5.76 points confirms a full year of lagging a rising market. The 10.2x trailing PE and 1.15x P/B sit below the 15-20x PE and 1.5-2.0x book typical of diversified P&C insurers, but the discount reflects genuine cyclicality concerns rather than a temporary mispricing. Sector rotation away from rate-sensitive financials and any deterioration in commercial real estate activity would compound the pressure.
In a worst-case scenario, a stall in the housing recovery combined with margin compression would drive earnings back toward the 2024 trough, forcing the multiple to contract toward the 7.5x low seen in Q4 2025. From the current $64.92, a decline to the 52-week low of $56.20 represents roughly -13.4%, and a break below the September 30 low of $60.74 would likely trigger momentum selling toward that level. A more severe scenario aligning with the -23.27% max drawdown would put the stock near $49.80, implying a loss of approximately -23% from current levels. The analyst low target of $79.00 is above the current price, so the downside is not reflected in sell-side estimates — the realistic bear case is a retest of the $56-57 zone, a -13% to -14% move.
FAQ
The most severe risk is cyclicality: title insurance revenue is levered almost entirely to real estate transaction volumes, and FAF posted a $104M net loss as recently as Q3 2024. Second is valuation compression — the 10.2x PE could contract toward the 7.5x low seen in Q4 2025 if margins compress, and the 1.259 beta amplifies drawdowns (the max drawdown is -23.27%). Third is technical breakdown risk: a break below the $60.74 September low would likely trigger momentum selling toward the $56.20 52-week low, a -13% move. Fourth is competitive disruption from digital title platforms and any deterioration in commercial real estate activity, which has been a key support for the recovery.
The 12-month forecast has three scenarios: a base case (50% probability) targeting $79-$85, aligned with the analyst average of $85.00 and consensus EPS of $7.49; a bull case (30% probability) targeting $85-$96, requiring multiple expansion toward the mid-teens PE and a housing volume rebound; and a bear case (20% probability) targeting $56-$65, retesting the 52-week low if margins compress. The base case is most likely, assuming earnings recover in line with consensus and the multiple stays near 9-11x forward earnings. The key assumption is that operating margins hold near 11% and commercial real estate strength offsets subdued residential purchase volumes.
FAF appears undervalued on multiple metrics. The 10.2x trailing PE and 8.94x forward PE sit below the 15-20x range typical of diversified P&C insurers, and the 1.15x price-to-book is below the 1.5-2.0x peer range. The 5.72x EV/EBITDA is below the 8-10x common for insurance peers, and the 0.85x price-to-sales is at the low end for a profitable specialty insurer. Relative to its own history, the current 10.2x PE sits in the lower-middle of a 7.5x-23.1x range, and the 1.15x P/B is near the low end of its 1.08x-1.50x band. The market is pricing FAF as if the earnings recovery will stall, implying that any confirmation of durable margins would drive a re-rating.
From a risk/reward perspective, FAF offers an attractive setup: the stock trades at 10.2x trailing and 8.94x forward earnings with a 13.1% FCF yield and 3.51% dividend yield, while the analyst average target of $85.00 implies 31% upside. The earnings recovery is real — EPS rose 51% YoY to $2.13 and net income has climbed for five consecutive quarters. The biggest downside risk is a retest of the 52-week low of $56.20, roughly -13% from the current $64.92, if housing volumes stall. This makes FAF a good buy for value-oriented investors with a 12-24 month horizon who can tolerate cyclical volatility, but less suitable for short-term traders given the 1.259 beta and the stock's 11.11% three-month decline.
FAF is better suited for medium-to-long-term investment than short-term trading. The 1.259 beta and -23.27% max drawdown mean short-term price action is volatile and driven by housing data and rate expectations, making it difficult to time. The 3.51% dividend yield and 13.1% FCF yield reward patient holders, and the cyclical recovery thesis needs several quarters to play out as title volumes normalize. Earnings visibility is moderate — consensus EPS has a tight $7.35-$7.62 range, signaling confidence in the near term — but the housing cycle introduces uncertainty beyond 12 months. A suggested minimum holding period is 12-18 months to capture the earnings recovery and potential multiple re-rating toward the $85 analyst target.

